.
BioEnterprise

NovelMed

NovelMed’s platform technologies have led to the development of monoclonal antibodies and small molecule therapies for the treatment of arthritis, cardiovascular disease, stroke and cancer.

Funding

Significant Grant Funding

Stage

Preclinical